About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  HISTORICAL VOLUME
Historical Volume      
Gland Pharma Ltd.
BSE Code 543245
ISIN Demat INE068V01023
Book Value 628.70
NSE Code GLAND
Dividend Yield % 0.99
Market Cap 300021.45
P/E 25.66
EPS 70.96
Face Value 1  
Exchange : Period From : Period To :
DateOpen Price(Rs.)High Price(Rs.)Low Price(Rs.)Close Price(Rs.)VolumeTurnover
20-Feb-2026 1836.30 1836.30 1815.25 1821.00 609 1109342
19-Feb-2026 1847.10 1874.45 1823.50 1836.25 1773 3290072
18-Feb-2026 1813.15 1872.00 1813.15 1847.00 3181 5895106
17-Feb-2026 1801.35 1841.00 1798.50 1833.85 1693 3081023
16-Feb-2026 1769.30 1814.80 1741.20 1809.25 1444 2588290
13-Feb-2026 1802.10 1805.35 1771.10 1779.65 1995 3566333
12-Feb-2026 1845.35 1853.90 1811.15 1815.30 2424 4455638
11-Feb-2026 1882.05 1885.90 1856.55 1866.05 1385 2589044
10-Feb-2026 1880.30 1893.70 1863.25 1883.70 2915 5476256
09-Feb-2026 1852.30 1890.00 1835.80 1885.10 5060 9438929
06-Feb-2026 1750.65 1863.70 1750.65 1852.05 2687 4935720
05-Feb-2026 1881.35 1897.00 1843.75 1849.80 1729 3227520
04-Feb-2026 1890.00 1901.00 1844.80 1885.80 4485 8372565
03-Feb-2026 1973.65 1975.00 1888.00 1894.15 6146 11827100
02-Feb-2026 1793.95 1915.00 1793.95 1897.40 15251 28567678
01-Feb-2026 1845.90 1866.00 1786.05 1838.00 4692 8551652
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.